Endo wins over Auxilium, QLT dropped
Endo is to acquire Auxilium Pharmaceuticals in a deal worth $2.6bn, just weeks after Auxilium's board unanimously rejected a previous $2.2bn offer (scripintelligence.com, 23 September 2014).
Endo is to acquire Auxilium Pharmaceuticals in a deal worth $2.6bn, just weeks after Auxilium's board unanimously rejected a previous $2.2bn offer (scripintelligence.com, 23 September 2014).